Interview with “The RedChip Money Report: Small Stocks Big Money”
will be broadcast in January
DELRAY BEACH, Fla.--(BUSINESS WIRE)--
VeriTeQ Corporation (“VeriTeQ”) (OTC Markets:VTEQ), a provider of
implantable medical device identification and radiation dose measurement
technologies, announced today that it is featured in an interview on
“The RedChip Money Report: Small Stocks Big Money”, which will be
broadcast on Fox Business and Bloomberg television networks. The
interview can currently be viewed online at http://youtu.be/F-UC5lBp2Ns.
Scott R. Silverman, VeriTeQ’s Chairman and Chief Executive Officer, was
recently interviewed by “The RedChip Money Report: Small Stocks Big
Money” host Dave Gentry, and discusses the Company’s technologies and
market opportunities for 2014 and beyond, including U.S. mandates that
are expected to drive product adoption.
Produced in RedChip's state-of-the-art studio in Orlando, "The RedChip
Money Report: Small Stocks Big Money" delivers insightful commentary on
small-cap investing, interviews with Wall Street analysts, financial
book reviews, as well as featured interviews with executives of public
companies. The show is hosted by Dave Gentry, a leading authority on
small-cap stocks and president of RedChip, an international small-cap
research firm and an Inc. 5000 company. Mr. Gentry has made multiple
guest appearances on both CNBC and Fox Business News and has been a
consultant to hundreds of public companies.
“The RedChip Money Report: Small Stocks Big Money” now reaches more than
215 million homes across the U.S., Europe and Asia through Bloomberg and
VeriTeQ develops innovative, proprietary RFID technologies for
implantable medical device identification, and dosimeter technologies
for use in radiation therapy treatment. VeriTeQ offers the world's first
FDA cleared RFID microchip technology that can be used to identify
implantable medical devices, in vivo, on demand, at the point of care.
VeriTeQ's dosimeters provide patient safety mechanisms while measuring
and recording the dose of radiation delivered to a patient in real time.
For more information on VeriTeQ, please visit www.veriteqcorp.com.
Statements in this press release and in the RedChip Money Report:
Small Stocks Big Money interview about our future expectations,
including, without limitation, the likelihood that the Company will meet
certain revenue projections and gross margin projections; constitute
"forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933, Section 21E of the Securities Exchange Act of
1934, and as that term is defined in the Private Litigation Reform Act
of 1995. Such forward-looking statements involve risks and uncertainties
and are subject to change at any time, and our actual results could
differ materially from expected results. These risks and uncertainties
include, without limitation, VeriTeQ’s ability to commercially launch
its Q Inside Safety Technology; the Company’s ability to target the UDI
sector and medical device manufacturers; VeriTeQ’s ability to raise
capital; as well as other risks. Additional information about these and
other factors may be described in VeriTeQ’s Forms 10-Q, filed on August
9, 2013 and November 14, 2013, and future filings with the Securities
and Exchange Commission The Company undertakes no obligation to update
or release any revisions to these forward-looking statements to reflect
events or circumstances after the date of this statement or to reflect
the occurrence of unanticipated events, except as required by law.
Allison Tomek, 561-846-7003
Source: VeriTeQ Corporation